Christian Gonzalez

https://assets.montefioreeinstein.org/profiles/images/physphoto/Gonzalez_Christian_MD.jpg

First Name

Christian

Last Name

Gonzalez

NPI

1568667160

Faculty ID

19689

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

4586

Is Open Scheduling

Off

Luigi Di Biase

https://assets.montefioreeinstein.org/profiles/images/physphoto/DiBiase_Luigi_MD_PhD_420x504.jpg

First Name

Luigi

Last Name

Di Biase

NPI

1891045837

Faculty ID

13629

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<blockquote>
<p class="lessPadding">Dr. Luigi Di Biase is Section Head of Electrophysiology, Director of Arrhythmia Services, and Professor of Medicine (Cardiology) at Einstein/Montefiore. In addition, he serves as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, Texas.</p>
<p>Improving patient care is the heart of Dr. Di Biase's mission. He believes that this is possible through dedicated clinical practice associated to cutting-edge clinical research. Dr. Di Biase's research focuses on cardiology and electrophysiology with specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices.</p>
<p>Dr. Di Biase, MD, PhD, FACC, FHRS, is a 2000 graduate (summa cum laude) of the medical school and a 2004 graduate (summa cum laude) of the cardiology residency program at the University of Bari, Bari, Italy. In 2006, he completed a second-level master degree in Electrophysiology and Pacing (summa cum laude) at the University of Insubria, Varese, Italy.</p>
<p>In 2007, Dr. Di Biase received a grant from the Italian National Society of Cardiology to pursue a research fellowship under the supervision of Dr. Andrea Natale at the Miller Family Heart &amp; Vascular Institute at the Cleveland Clinic, Cleveland, Ohio. The following year, he accepted a position in cardiac electrophysiology at the University of Texas Medical School Branch in Galveston, Texas, where he continued to focus on his research projects at St. David's Medical Center under the leadership of Dr. Natale.</p>
<p>Dr. Di Biase was appointed Assistant Professor in 2007 at the University of Foggia, Italy, where he completed the PhD program in cardiovascular physiopathology in November 2010.</p>
<p>In 2009, Dr. Di Biase was appointed Adjunct Assistant Professor at the University of Texas at Austin, where he was promoted to Adjunct Associate Professor in 2012, the same year he joined Albert Einstein College of Medicine and Montefiore Medical Center&nbsp;with the title of Associate Professor, Department of Medicine (Cardiology).</p>
<p>In September 2014 Dr. Di Biase was appointed Section Head of Electrophysiology and Director of Arrhythmia Services at Einstein/Montefiore, while continuing to serve as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center.&nbsp;</p>
<p>Subsequently Dr. Di Biase was promoted to the rank of Professor of Medicine, Department of Medicine (Cardiology).</p>
<p>Dr. Di Biase is the author of more than 450 publications in indexed journals, about 500 abstracts, and 18 electrophysiology book chapters. He has presented at numerous national and international conferences as an invited speaker.</p>
<p class="lessPadding">Dr. Di Biase is a member of the Italian Federation of Cardiology and Electrophysiology (FIC-AIAC), the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA), the American College of Cardiology (ACC), the American Heart Association (AHA), and a Fellow of the Heart Rhythm Society (FHRS), and the American College of Cardiology (FACC). He is also an honorary member of the Korean Society of Cardiology.</p>
<p class="lessPadding">Dr Di Biase serves as reviewer of major electrophysiology and cardiology journals, and as an editorial board member of&nbsp;<em>Heart Rhythm Journal</em>,&nbsp;<em>Heart Rhythm Journal Case Report</em>, and&nbsp;<em>Journal of Cardiovascular Medicine</em>. He is Associate Editor for&nbsp;<em>Journal Interventional Cardiac Electrophysiology (JICE)</em>&nbsp;and Associate Section Editor for&nbsp;<em>Pacing and Clinical Electrophysiology (PACE)</em>.</p>
<p class="lessPadding">Dr. Di Biase sees patients on both Einstein and Moses campuses of Montefiore Medical Center and at the Hutch Metro Center at Water Place.</p>
<p class="lessPadding"><strong><br /></strong></p>
<p class="lessPadding"><strong>More Information About Dr. Luigi Di Biase</strong></p>
<p class="lessPadding"><a href="http://www.einstein.yu.edu/departments/medicine/divisions/cardiology/ne… is More in Ablation for Ventricular Arrhythmia</a></p>
<p><a href="http://www.einstein.yu.edu/departments/medicine/divisions/cardiology/ne…; target="blank">Can the shape of the left atrial appendage affect stroke risk?</a></p>
<p><a href="http://www.einstein.yu.edu/departments/medicine/divisions/cardiology/ne…; target="blank">Continuous Warfarin Therapy for Patients Undergoing Catheter Ablation</a></p>
</blockquote>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Improving patient care is the heart of Dr. Di Biase's mission. He believes this is possible through dedicated clinical practice associated to cutting-edge clinical research.</p>

Research Focus

<p>Dr. Di Biase's research focuses on cardiology and electrophysiology with specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices.</p>

Elsevier Profile

Selected Publications

<ol>
<li>Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, Gallinghouse GJ, Bailey SM, Zagrodzky JD, Santangeli P, Hao S, Hongo R, Beheiry S, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Al-Ahmad A, Wang P, Cummings JE, Schweikert RA, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Lewis WR, Natale A. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122:109-18. PMID 20606120.</li>
<li>Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Della Russo A, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121:2550-6. Epub 2010 Jun 1. PMID: 20516376.</li>
<li>Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, Gallinghouse GJ, Themistoclakis S, Rossillo A, Lakkireddy D, Reddy M, Hao S, Hongo R, Beheiry S, Zagrodzky J, Rong B, Mohanty S, Elayi CS, Forleo G, Pelargonio G, Narducci ML, Dello Russo A, Casella M, Fassini G, Tondo C, Schweikert RA, Natale A. Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management: Results From the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) Randomized Trial. Circulation. 2014 ;129:2638-44.</li>
<li>Di Biase L, Santangeli P, Burkhardt D, Bai R, Mohanty P, Carbucicchio C, Dello Russo A, Casella M, Mohanty S, Pump A, et al. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2012; 60:132-141.</li>
<li>Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, Horton R, Sanchez JE, Bai R, Mohanty S, Pump A, Mauricio Cereceda Brantes, Gallinghouse GJ, Burkhardt JD, Federico Cesarani, Scaglione M, Natale A, Gaita F. Does the left atrial appendage morphology correlate with the risk of stroke in patients with AF? Result from a multicenter study. J Am Coll Cardiol. 2012;60:531-8.</li>
</ol>

EMR ID

5640

Biography

<p>Luigi Di Biase, MD, PhD, FACC, FHRS, is Section Head of Electrophysiology and Director of Arrhythmia Services at Montefiore as well as Professor of Medicine (Cardiology) at our&nbsp;<a href="http://www.einstein.yu.edu/faculty/13629/luigi-di-biase/&quot; target="_blank" rel="noopener noreferrer">Albert Einstein College of Medicine</a>.</p><p>Dr. Di Biase attended University of Bari in Bari, Italy, graduating&nbsp;from its medical school in 2000 and Cardiology residency program in 2004. In 2006, he completed a second-level master&rsquo;s degree in Electrophysiology and Pacing at the University of Insubria, in Varese, Italy.</p><p>In 2007, Dr. Di Biase received a grant from the Italian National Society of Cardiology to pursue a research fellowship at the Miller Family Heart &amp; Vascular Institute at the Cleveland Clinic. Dr. Di Biase completed the PhD program in cardiovascular physiopathology at the University of Foggia, Italy, in 2010.</p><p>Dr. Di Biase's research focuses on cardiology and electrophysiology, with an emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. His research focuses on heart failure, particularly in cases treated with cardiac resynchronization therapy devices.</p><p>Dr. Di Biase is the author of more than 450 publications in indexed journals, roughly 500 abstracts, and 16 electrophysiology book chapters. He has presented as an invited speaker at numerous national and international conferences and serves as Associate Editor for Pacing and Clinical Electrophysiology (PACE) as well as&nbsp;the Journal of Interventional Cardiac Electrophysiology (JICE). He is the Editorial Team Lead for the American College of Cardiology in the field of Electrophysiology. He co-authored the 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation, which is globally referenced for best-practices in cardiac ablation.</p><p>Dr. Di Biase is the highest published Electrophysiology faculty member and is also one of the world&rsquo;s most published physicians on the topic of cardiac electrophysiology and atrial fibrillation.<br /><br /> Dr. Di Biase is a member of the Italian Federation of Cardiology and Electrophysiology (FIC- AIAC), the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA), the American College of Cardiology (ACC), and the American Heart Association (AHA). He is a fellow of the Heart Rhythm Society (FHRS) and the American College of Cardiology (FACC), and is an honorary member of the Korean Society of Cardiology.</p>

Is Open Scheduling

Off

Jay J. Chudow

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/5fda4540-7adb-11ed-bf65-b1a6006850f8.jpg

First Name

Jay

Last Name

Chudow

NPI

1669828075

Faculty ID

17421

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Jay Chudow, MD is an attending cardiologist at the Montefiore-Einstein Center for Heart &amp; Vascular care. He is interested in clinical cardiology, effects of time changes on cardiovascular health and applications of innovative technology within cardiology, such as artificial intelligence interpretation of the electrocardiogram.</p>
<p>Dr. Chudow grew up in the Hudson Valley. He graduated from Columbia University with a degree in Civil Engineering in 2009. He coordinated oncology clinical trials at Memorial Sloan-Kettering Cancer Center before earning his medical degree from Stony Brook University School of Medicine in 2016. He then came to Montefiore-Einstein for internal medicine residency training followed by cardiovascular fellowship training, where he served as a chief fellow, graduating in 2022. He participated in the inaugural class of the Montefiore-Einstein Innovation &amp; Biodesign program in the 2020-2021 academic year. He was awarded the James Scheuer, MD Memorial Teaching Award in 2022.</p>
<p>His work on daylight saving time transitions and atrial fibrillation has been featured on national news, including National Public Radio (NPR).</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Clinical Cardiology, Preventive Cardiology, Echocardiography, Non-invasive Cardiac Imaging

Research Focus

Effects of time changes on cardiovascular health, applications of innovative technology within cardiology. His work on daylight saving time transitions and atrial fibrillation has been featured on national news, including National Public Radio (NPR).

Elsevier Profile

Selected Publications

<p class="MsoNoSpacing"><strong>Chudow JJ</strong>, Dreyfus I, Zaremski L, Mazori AY, Fisher JD, Di Biase L, Romero J, Ferrick KJ, Krumerman A. <em>Changes in Atrial Fibrillation Admissions Following Daylight Saving Time Transitions.</em> Sleep Medicine 2020 May; 69:155-158 PMID: 32088351</p>
<p class="MsoNoSpacing" style="tab-stops: 5.5in;"><strong>Chudow JJ</strong>, Jones D, Weinreich M, Zaremski L, Lee S, Weinreich B, Krumerman A, Fisher J, Ferrick KJ. <em>A Head-to Head Comparison of Deep Learning Algorithms for Identification of Implanted Cardiac Devices.</em> Am J Cardiol. 2021 Apr 1;144:77-82. PMID: 33383004.</p>
<p class="MsoNoSpacing" style="tab-stops: 5.5in;">Friedman A, <strong>Chudow JJ</strong>, Merritt Z, Shulman E, Fisher JD, Ferrick KJ, Krumerman A. <em>Electrocardiogram Abnormalities in an Older Individuals by Race and Ethnicity.</em> J Electrocardiol. 2020 Nov-Dec;63:91-93. Epub 2020 Oct 4. PMID: 33152549</p>

EMR ID

87564

Visit Type ID

2497

Is Open Scheduling

On

Zocdoc Link

Lili Zhang

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/acc2b8e0-d37c-11eb-9aaf-2d15ec0e1e68.jpg

First Name

Lili

Last Name

Zhang

NPI

1992066948

Faculty ID

16495

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Non-invasive cardiology, echocardiography, cardio-oncology, multimodality cardiovascular imaging

Research Focus

Cardiotoxicity of cancer therapy, immune checkpoint inhibitor myocarditis, and the application of multimodality imaging and machine-learning techniques in cardiovascular disease.

Elsevier Profile

EMR ID

56187

Biography

<p>Lili Zhang, MD, is Director, Cardio-Oncology Program and Assistant Professor, Cardiology at Montefiore Einstein. A non-invasive cardiologist and a cardiac imaging specialist, Dr. Zhang&rsquo;s clinical focus is in Cardio-Oncology, cardiomyopathy, general cardiology, echocardiography and multimodality cardiac imaging.</p><p>In 2007, Dr. Zhang earned her Doctor of Medicine degree at Peking University, Beijing, China. Further education and postdoctoral training brought her to the U.S., completing her Master of Science in Epidemiology at Johns Hopkins Bloomberg School of Public Health in 2011. She then came to Einstein, completing her residency in internal medicine in 2015 and her fellowship in cardiology in 2018. In 2019, Dr. Zhang completed her fellowship in Cardio-Oncology and cardiac imaging at Massachusetts General Hospital.</p><p>Dr. Zhang&rsquo;s research focuses on cardiotoxicity of cancer therapy, immune checkpoint inhibitor myocarditis, cardiovascular care and the application of multimodality imaging and machine-learning techniques in cardiovascular disease. Her research experience includes retrospective studies, prospective cohorts (ARIC and CHS), large multi-cohort consortiums (CHARGE and PAGE consortiums), randomized clinical trials (PROMISE trial), and international collaborative registries (international immune checkpoint inhibitor myocarditis registry and Global Cardio Oncology Registry). She has shared her work through more than 60 manuscripts in peer-reviewed journals and abstract publications.</p><p>Dr. Zhang is board certified in Internal Medicine and Cardiovascular Disease. She is a Fellow of the American College of Cardiology, and is a member of the American Heart Association and the international Cardio-Oncology Society. In 2021, she was awarded the Glorney-Raisbeck Junior Faculty Research Award in Cardiovascular Disease by New York Academy of Medicine.</p>

Is Open Scheduling

Off

Michael Yee

https://assets.montefioreeinstein.org/profiles/images/13771-michael-yee.jpg

First Name

Michael

Last Name

Yee

NPI

1699971085

Faculty ID

13771

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5456

Is Open Scheduling

Off

Samson Wiseman

https://assets.montefioreeinstein.org/profiles/images/physphoto/Wiseman_Samson_MD_420x504.jpg

First Name

Samson

Last Name

Wiseman

NPI

1588761316

Faculty ID

10181

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4748

Is Open Scheduling

Off

Daniel A. Weiser

https://assets.montefioreeinstein.org/profiles/images/Weiser_Daniel_MD_2x.jpg

First Name

Daniel

Last Name

Weiser

NPI

1225239700

Faculty ID

13846

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span style="text-decoration: underline;"><strong>Childhood cancer research laboratory</strong></span></p>
<p>Our laboratory is focused on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. In such patients with typically incurable cancer, we are striving to identify new approaches to and types of treatment. We have multiple ongoing projects:</p>
<p><strong>+ Identification of biologic drivers of ultra-high-risk neuroblastoma</strong>. Neuroblastoma is one of the most common and deadly childhood cancers. Despite intensive research, there are limited therapeutic strategies for patients with <em>de novo </em>chemotherapy resistance that leads to particularly poor outcomes. We have been studying neuroblastoma since 2009 and are identifying additional biologic drivers of highly lethal tumors.</p>
<p>We compare tumor features from patients with early death from tumor progression compared to those with a maintained complete response. We assess unique histo-morphologic and proteomic features and computationally integrate these data with genomic and transcriptomic datasets to develop a combined predictor of primary refractory disease. Patients with this entity require non-standard and/or intensified treatment. Oncogenic drivers are being characterized in the lab which will facilitate strategies for novel pharmacologic intervention.</p>
<p><strong>+ Characterization of neuroblastoma development from neural crest cells</strong>.&nbsp; We are studying pathways and interactions that results in uncontrolled cell proliferation early in neuroblastoma development with an ultimate goal of identifying new targets and approaches for pharmacologic intervention.</p>
<p><strong>+ Evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma</strong>.&nbsp; With expected outcomes lagging behind those of more common childhood cancers, children with neuroblastoma require new approaches to treatment. Our lab works with multiple international clinical and research consortium groups to perform preclinical studies that substantiate human clinical trials.&nbsp;</p>
<p><strong>+ Detection of circulating tumor DNA in osteosarcoma</strong>. With no reliable non-invasive approach for disease monitoring during and after treatment, we are applying cutting edge next-generation sequencing approaches to identify solid tumors with a blood-based &ldquo;liquid&rdquo; biopsies. This will allow clinicians to assess tumor responsiveness to chemotherapy and predict likelihood of recurrence.</p>
<p><strong>+ Assessment of accelerated aging using miRNA-seq in survivors of childhood cancer</strong>. Chemotherapy has many untoward effects on healthy cells and leads to many signs of accelerated aging in children treated for cancer. Using a known microRNA &ldquo;aging&rdquo; signature discovered at Albert Einstein College of Medicine, we are studying what causes this phenotype in childhood cancer, with a goal of offering improved intervention to minimize long-term toxicity of treatment.</p>
<p><strong><span style="text-decoration: underline;">Physician Summary</span></strong></p>
<p>Daniel A. Weiser, MD, is board-certified in pediatric hematology/oncology with clinical expertise in neuroblastoma and other tumors of the adrenal glands, kidneys, liver, and gonads. He is the medical director of the intra-abdominal solid tumor program at the Children&rsquo;s Hospital at Montefiore and brings together a highly specialized multi-disciplinary care team to provide comprehensive treatment for diverse pediatric malignancies. In addition, Dr. Weiser directs a childhood cancer research laboratory that focuses on the identification of new targeted agents for cancer therapy, especially in the treatment of rare and aggressive malignancies such as neuroblastoma. His research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise for improving management of all patients with solid tumors.</p>
<p>Dr. Weiser participates in the efforts of a number of professional organizations including the Children&rsquo;s Oncology Group (COG), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), Advances in Neuroblastoma Research Association (ANRA), National Pediatric Cancer Foundation (NPCF), and the American Academy of Pediatrics (AAP). He has received numerous awards including the Brigid Leventhal Special Merit Award from ASCO and the Conquer Cancer Foundation, and a prestigious K12 from the National Cancer Institute for the training of the next generation of physician-scientists in pediatric cancer. Dr. Weiser is actively involved in teaching and mentorship of trainees, and takes great pride in providing advanced and compassionate care to his patients and their families.</p>
<p><strong>Clinical Expertise</strong></p>
<ul>
<li>Neuroblastoma (adrenal tumors)</li>
<li>Wilms tumor (renal tumors)</li>
<li>Hepatoblastoma (liver tumors)</li>
<li>Germ cell tumors (including testicular and ovarian tumors)</li>
<li>Thyroid and other rare tumors</li>
<li>Experimental therapeutics</li>
<li>Cancer genetics and biomarkers</li>
</ul>
<p><strong>Board Certifications</strong></p>
<ul>
<li>Pediatrics</li>
<li>Pediatric Hematology/Oncology</li>
</ul>
<p><strong>Professional Education</strong></p>
<ul>
<li>M.D. &ndash; Stony Brook University, NY</li>
<li>Residency &ndash; Children&rsquo;s Hospital of NY-Presbyterian, Columbia University, NY</li>
<li>Chief Residency &ndash; Children&rsquo;s Hospital of NY-Presbyterian, Columbia University, NY</li>
<li>Fellowship &ndash; The Children&rsquo;s Hospital of Philadelphia, PA</li>
</ul>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

DR. Weiser's clinical focuses are neuroblastoma and adrenal tumors, Wilms tumor and other kidney (renal) tumors, hepatoblastoma, and other liver tumors, germ cell tumors (including testicular and ovarian tumors), Thyroid and other rare tumors, experimental therapeutics, and cancer genetics and biomarkers.&nbsp;

Research Focus

Dr. Weiser&rsquo;s research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise in the treatment of all solid tumors. Dr. Weiser&rsquo;s laboratory focuses on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. He has multiple ongoing projects, such as identification of biologic drivers of neuroblastoma at ultra-high risk for treatment failure, characterization of neuroblastoma development from neural crest cells, and evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma, among others.

Elsevier Profile

EMR ID

5755

Biography

<p>Daniel A. Weiser, MD, is a Medical Director of the Intra-abdominal Solid Tumor Program in the Pediatrics Hematology/Oncology department at Children&rsquo;s Hospital at Montefiore. He is also Associate Professor in the Pediatrics and Genetics departments at the Albert Einstein College of Medicine. His clinical focuses are neuroblastoma and adrenal tumors, Wilms tumor and other kidney (renal) tumors, hepatoblastoma and other liver tumors, germ cell tumors (including testicular and ovarian tumors), Thyroid and other rare tumors, experimental therapeutics, and cancer genetics and biomarkers. Dr. Weiser is actively involved in teaching and mentorship of trainees and takes great pride in his active participation in patient care.</p><p>Dr. Weiser received his Bachelor of Science in Neurobiology in 1995 at Haverford College, PA. In 2004, he received his Doctor of Medicine at Stony Brook University School of Medicine, NY. He is currently earning his Master of Science in Translational Research at the University of Pennsylvania. He began a residency in Pediatrics at the New York-Presbyterian, Columbia University in 2007. Dr. Weiser then completed a three-year fellowship in Pediatric Hematology/Oncology at The Children&rsquo;s Hospital of Philadelphia. </p><p>Dr. Weiser&rsquo;s research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise in the treatment of all solid tumors. Dr. Weiser&rsquo;s laboratory focuses on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. He has multiple ongoing projects, such as identification of biologic drivers of neuroblastoma at ultra-high risk for treatment failure, characterization of neuroblastoma development from neural crest cells, and evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma, among others. His research has been published in many reviewed journals. </p><p>Dr. Weiser participates in the efforts of a number of professional organizations including the Children&rsquo;s Oncology Group (COG), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), and the American Academy of Pediatrics (AAP). He has received many awards including the Brigid Leventhal Special Merit Award through ASCO, and he has been awarded a prestigious K12 from the NCI for the training of the next generation of physician-scientists in pediatric cancer.</p><p>He is board certified in Pediatric Hematology/Oncology and General Pediatrics.</p>

Is Open Scheduling

Off

Jacqueline Weingarten-Arams

https://assets.montefioreeinstein.org/profiles/images/physphoto/Weingarten_Jacqueline_MD_420x504.jpg

First Name

Jacqueline

Last Name

Weingarten-Arams

NPI

1558447409

Faculty ID

4831

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

Lab Website Link

EMR ID

3961

Biography

<p>Jacqueline Weingarten-Arams, MD, is an attending physician and Professor, Pediatrics at Montefiore Einstein. Dr. Weingarten-Arams&rsquo; pediatric critical care expertise focuses on cardiac critical care, acute hypoxemic respiratory failure, nutrition in critical illness and energy expenditure, cardiopulmonary resuscitation (quality CPR) and extracorporeal life support (ECMO).</p><p>After obtaining her Bachelor of Science in nutritional biochemistry at Cornell University in 1982, Dr. Weingarten-Arams earned her Doctor of Medicine at the same institution in 1986. She then completed her pediatric residency at Columbia University in 1990, where she was Chief Resident in her final year. Following this, Dr. Weingarten-Arams completed a fellowship in pediatric critical care medicine at New York Hospital Cornell University Medical College in 1996.</p><p>Dr. Weingarten-Arams research focus includes the use of deliberate simulated practice in improving outcomes in pediatric critical illness, pediatric resuscitation and pediatric airway management. Her other projects involve chronic critical illness, bioethics in pediatric critical care and oxidative injury in respiratory failure. She has been principal investigator and co-investigator on several research projects, and her work has been shared through numerous peer-reviewed publications and invited presentations.</p><p>Dr. Weingarten-Arams is a Diplomate of the National Board of Medical Examiners and the American Board of Pediatrics. She is a Fellow of the American Academy of Pediatrics and the American College of Chest Physicians. She is also a member of several professional organizations, including the American Medical Association, the Pediatric Cardiac Intensive Care Society and the Society of Critical Care Medicine. Dr. Weingarten-Arams has been named in Castle Connolly&rsquo;s &ldquo;Top Doctors: New York Metro Area&rdquo; for multiple years. In 2006, she was inducted into the Leo M. Davidoff Society and in 2019, Dr. Weingarten-Arams won the William Obrinsky Award for Excellence in Medical Student Education.</p>

Is Open Scheduling

Off

Ana Y. Valdivia

https://assets.montefioreeinstein.org/profiles/images/physphoto/Valdivia_Ana_MD_420x504.jpg

First Name

Ana

Last Name

Valdivia

NPI

1184728404

Faculty ID

8283

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4272

Biography

<p>Ana Y. Valdivia, MD, is an attending physician at Montefiore Einstein and Assistant Professor, Diagnostic Radiology at our Albert Einstein College of Medicine. Dr. Valdivia&rsquo;s clinical focus involves all aspects of nuclear medicine, with a particular focus on positron emission tomography&ndash;computed tomography (PET-CT).</p><p>After receiving her Bachelor of Science in chemistry at the University of Puerto Rico in 1990, Dr. Valdivia attended Universidad Central del Caribe School of Medicine, earning her Doctor of Medicine in 1994. She completed her internal medicine residency at Veterans Affairs Medical Center in 1997, followed by her nuclear medicine residency at Mount Sinai Medical Center in 1999.</p><p>Dr. Valdivia&rsquo;s research involves PET-CT, frequently focusing on brain imaging. She has shared her research through peer-reviewed journals, book chapters, abstracts, exhibits, and oral and poster presentations. She is also an invited reviewer for the International Journal of Surgery.</p><p>Dr. Valdivia is board certified by the American Board of Internal Medicine and the American Board of Nuclear Medicine. She is a member of the Society of Nuclear Medicine and the American College of Radiology.</p>

Is Open Scheduling

Off

Henry Michael Ushay

https://assets.montefioreeinstein.org/profiles/images/physphoto/Ushay_Michael_MD_420x504.jpg

First Name

Henry

Last Name

Ushay

NPI

1558332007

Faculty ID

10275

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric critical care medicine with a special emphasis on respiratory failure; shock resuscitation; cardiac intensive care; intensive care of pediatric oncology patients; extracorporeal support for children with respiratory and cardiovascular failure

Research Focus

Leadership and direction of the 16-bed Pediatric Critical Care Unit of The Children&rsquo;s Hospital at Montefiore; improving medication safety; respiratory physiology; advances in the management of respiratory failure in children; shock; medical ethics

Elsevier Profile

EMR ID

4763

Biography

<p>Dr. Ushay is Professor of Clinical Pediatrics in the Albert Einstein College of Medicine. He is a Fellow of the American Academy of Pediatrics as well as a Fellow of the American College of Critical Care Medicine. </p><p>After obtaining a PhD in Chemistry from Columbia University, Dr. Ushay received his MD from UMDNJ-New Jersey Medical School and completed a Pediatrics residency in the Montefiore-Jacobi-Einstein program. After serving as Chief Resident and a Fellow in Pediatric Pulmonology at Montefiore, he completed a Pediatric Critical Care Fellowship at New York Hospital/Cornell Medical Center in 1993. He was a faculty member at NewYork-Presbyterian and Memorial Sloan-Kettering Hospitals from 1993 to 2005, and he served as Pediatric Critical Care Medicine Fellowship Program Director and Medical Director of the Pediatric Observation Unit at Memorial Sloan-Kettering Cancer Center. </p><p>In 2005 Dr. Ushay became Director of the Pediatric Critical Care Unit in The Children&rsquo;s Hospital at Montefiore. Dr. Ushay is involved in increasing pediatric ICU surge capacity through the New York City Pediatric Disaster Coalition, serving on its Central Leadership Council and teaching the Pediatric Fundamental Critical Care Support Course. Through the National Institute of Child Health and Human Development, Dr. Ushay works on employing medical countermeasures safely for children in the event of chemical, biological or radiological disaster. Sponsored by Surgeons of Hope and Children&rsquo;s HeartLink, Dr. Ushay has worked as a cardiac intensivist in Cambodia, Africa, China and Nicaragua. </p>

Is Open Scheduling

Off